IPIRA Startups

IPIRA Startups

ReRx Therapeutics

Brief Description

ReRx is developing novel oral therapeutics to treat patients with severe metabolic diseases including obesity, metabolic syndrome, diabetes, and liver diseases. The company's therapeutics target metabolic pathways involved in regulating energy homeostasis and improve treatment outcomes compared to similar pharmacological agents.

Timeline 2023. Company founded Inventors

Chi Zhu, Anders Michael Naar, Justin Yu-Sun Lee

RareTerra, Inc.

Brief Description

RareTerra is developing a one-step environmentally friendly bio-process for selective rare-earth element (REE) extraction, separation, and purification that doesn't rely on harsh acids or high temperatures and pressures. RareTerra’s technology eliminates the costliest and most hazardous steps of the manufacturing process, and is compatible with complex, dilute, and waste REE sources. The company's proprietary process leverages the power of genetic and metabolic engineering to unlock the remarkable capacity of microbes to separate REEs from other metals and bioaccumulate...

Quadrant Imaging

Brief Description

LAMDA-based (laser amplified motion detection and analysis) ultra-high resolution optical microscopes with high-density data storage system, using a method of laser feedback interferometry which permits the imaging of nanometer-scale structures.

Timeline 1995. Company founded Inventors

Alan J. Bearden, Michael P. O'Niell

GenoptX, LLC

Brief Description

A CRISPR-based gene editing company.

Formerly known as Syncodi.

Timeline 2019. Company founded. Inventors

Jennifer Doudna, Abraham Isser Flamholz, Dana Nadler, Benjamin Oakes, David Frank Savage

Geneditor Biosciences, Inc.

Brief Description

Geneditor Biosciences is a pre-clinical stage gene editing company focused on the treatment of rare cancers with unmet medical needs.

Timeline 2021. Company founded. Inventor

Jennifer Doudna

Evercrisp Biosciences

Brief Description

Evercrisp Biosciences is a biotechnology company engineering self-deliverable CRISPR genome editors intended to improve the area of oncology. The company focuses on the discovery and development of protein-based genome editors as therapeutics for multiple disease areas, enabling healthcare organizations to have novel enzymes with high cell permeability and editing efficiency.

Timeline 2021. Company founded. Inventor

Jennifer Doudna

Secured Streams, Inc.

Brief Description

Software for document content search and comparison from large sets or across the web.

Timeline 2005. Company founded Inventors

Alexander Aiken, Joel Auslander, Steve Fink, Saul Schleimer, Anthony Tomasic, Daniel Wilkerson

EditPep, Inc.

Brief Description

CRISPR therapies enabled by a simple, potent delivery platform. The biotechnology company creates a class of peptides capable of delivering CRISPR enzymes into clinically-relevant and previously untransfectable cell types, enabling clients to get CRISPR therapies.

Timeline 2021. Company founded. 2023. Company participated Berkeley SkyDeck accelerator, Batch 16. Inventor

Ross Wilson, Dana Foss, Alexander Marson, Srishti Sahu, David-Huy Nguyen, John Hunsinger, Daniel Carr

nEye Systems

Brief Description nEye Systems is a next-generation optical switch company. Their programmable photonic integrated circuit integrates high-radix optical circuit switching on a Si chip and is a future-proof solution for Artificial Intelligence (AI)/Machine Learning (ML) systems and other high-performance computing environments. Their optical switches are poised to solve some of the biggest challenges facing the growth and adoption of AI/ML – the excessive costs of power requirements and network expansion. Timeline 2020. Company founded. Inventors

Sangyoon Han,...

Myo Corps

Brief Description

Measuring muscle mass through analysis of creatinine in urine samples. The company's proprietary D3Creatine dilution method to measure muscle mass, termed the Muscle Assessment Test (MAT), is being used to assess muscle mass in several NIH sponsored cohort studies including the Framingham Heart Study, Women's Health Inititiative, Tobago Longitudinal Aging Study, the Study on Muscle, Mobility, and Aging (SOMMA), and more. The goal is to achieve FDA approval for the MAT as a diagnostic test for muscle mass.

MyoCorps CEO William J. Evans, PhD, is an...